Confo Therapeutics
Lies Dekeyzer is a highly experienced scientist in the field of assay development and screening. Currently serving as Principal Scientist at Confo Therapeutics since January 2018, Lies has progressed through various roles including Senior Scientist and Scientist on the Screening Team. Prior to this, Lies worked at Ablynx from January 2007 to December 2017 in multiple positions ranging from Associate Scientist to Senior Research Associate and Research Associate, focusing on lead characterization within discovery. Lies began a scientific career as a Lab Technician in the Laboratory for Neurobiology and Gene Therapy at KU Leuven from March 2005 to December 2006. Educationally, Lies holds a Master’s degree in Biomedical Sciences from KU Leuven, obtained between 2000 and 2004, and completed secondary education at Sint-Andreaslyceum in Brugge from 1994 to 2000.
This person is not in any teams
This person is not in any offices
Confo Therapeutics
1 followers
Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for GPCR drug discovery.